You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myelodysplastic Syndromes

Showing 1 - 25 of 3,172
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS Trial in Hangzhou (IV Decitabine, Decitabine and cedazuridine, only Decitabine and cedazuridine)

Recruiting
  • Myelodysplastic Syndromes
  • IV Decitabine
  • +2 more
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital,Zhejiang University School of Medi
Oct 23, 2023

Lower Risk MDS Per IPSS-R Trial (Luspatercept)

Not yet recruiting
  • Lower Risk MDS Per IPSS-R
  • (no location specified)
Jun 21, 2023

MDS Trial run by the National Cancer Institute (NCI) (KPT-8602, Inqovi)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 30, 2023

MDS, Ferroptosis Trial in Pessac (Biological sampling)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Ferroptosis
  • Biological sampling
  • Pessac, France
  • +2 more
Jun 19, 2023

MDS Trial in Houston (Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2023

MDS Trial run by the National Cancer Institute (NCI) (decitabine and cedazuridine, BMS-986253)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

MDS Trial (Imetelstat)

Available
  • Myelodysplastic Syndromes
  • (no location specified)
Jun 30, 2023

Biospecimen Acquisition for Myelodysplastic Syndromes

Recruiting
  • Myelodysplastic Syndromes
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 20, 2022

    MDS Trial (Decitabine/Cedazuridine, Magrolimab)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • (no location specified)
    Apr 18, 2023

    Acute Myeloid Leukemia, MDS Trial in Rochester, Houston (CTX-712)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Rochester, Minnesota
    • +1 more
    Feb 15, 2023

    Samples of Bone Marrow Aspiration From Myelodysplastic Syndrome

    Recruiting
    • Myelodysplastic Syndromes
    • Blood test
    • Jerusalem, Israel
      Shaare Zedek Medical Center
    Nov 16, 2023

    Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

    Recruiting
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +2 more
    • VEN+AZA+Modified BUCY
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Apr 10, 2023

    Relapsed / Refractory MDS Trial (NCR300)

    Not yet recruiting
    • Relapsed / Refractory Myelodysplastic Syndromes
    • (no location specified)
    May 7, 2022

    Interplay Between Immune and Metabolic Programs in

    Recruiting
    • Myelodysplastic Syndromes
      • Toulouse, France
        IUCT-Oncopole University Hospital
      May 17, 2022

      Low Risk MDS Trial (R906289 Monosodium (R289 Na))

      Not yet recruiting
      • Low Risk Myelodysplastic Syndromes
      • R906289 Monosodium (R289 Na)
      • (no location specified)
      Jul 22, 2022

      High Grade MDS Trial in Aurora (Omacetaxine, Azacitidine)

      Recruiting
      • High Grade Myelodysplastic Syndromes
      • Aurora, Colorado
        Universtiy of Colorado Denver
      Nov 17, 2022

      Myeloid Leukemia, MDS Trial (IFN-?)

      Not yet recruiting
      • Myeloid Leukemia
      • Myelodysplastic Syndromes
      • (no location specified)
      Nov 15, 2023

      AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)

      Not yet recruiting
      • AML/MDS
      • +2 more
      • (no location specified)
      Aug 14, 2023

      MDS, MDS Trial in Tampa, Boston, Houston (APR-548 + Azacitidine)

      Terminated
      • MDS
      • Myelodysplastic Syndromes
      • APR-548 + Azacitidine
      • Tampa, Florida
      • +3 more
      Jul 20, 2022

      Clonal Cytopenia of Undetermined Significance, MDS Trial in Saint Louis (Atorvastatin, Rosuvastatin)

      Not yet recruiting
      • Clonal Cytopenia of Undetermined Significance
      • Myelodysplastic Syndromes
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jul 28, 2022

      MDS, Myelodysplastic Anemia, Myelodysplastic Syndrome With Isolated Del(5Q) Trial (description of MDS pzatient cohort)

      Recruiting
      • Myelodysplastic Syndromes
      • +5 more
      • description of MDS pzatient cohort
      • Brest, France
        Chu Brest
      Oct 27, 2022

      Anemia Trial (Luspatercept)

      Not yet recruiting
      • Anemia
      • Luspatercept
      • (no location specified)
      May 26, 2023

      Acute Myeloid Leukemia, MDS Trial in Rochester (Inpatient serious illness care program)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndromes
      • Inpatient serious illness care program
      • Rochester, New York
        University of Rochester
      Jun 21, 2022

      Haplo-HSCT for Elderly Acute Leukemia/ Myelodysplastic Syndrome

      Not yet recruiting
      • Acute Leukemia
      • Myelodysplastic Syndromes
        • Beijing, Beijing, China
          Peking University People's Hospital
        Jun 5, 2023

        MDS Trial in Seoul (cyclophosphamide, fludarabine, and antithymocyte globulin)

        Active, not recruiting
        • Myelodysplastic Syndromes
        • cyclophosphamide, fludarabine, and antithymocyte globulin
        • Seoul, Korea, Republic of
          Asan Medical Center, University of Ulsan College of Medicine
        Oct 19, 2023